|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tahara E: Genetic pathways of two types of
gastric cancer. IARC Sci Publ. 157:327–349. 2004.PubMed/NCBI
|
|
3
|
Owens GP, Hahn WE and Cohen JJ:
Identification of mRNAs associated with programmed cell death in
immature thymocytes. Mol Cell Biol. 11:4177–4188. 1991.PubMed/NCBI
|
|
4
|
Kawakami T, Furukawa Y, Sudo K, et al:
Isolation and mapping of a human gene (PDCD2) that is highly
homologous to Rp8, a rat gene associated with programmed cell
death. Cytogenet Cell Genet. 71:41–43. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Merup M, Moreno TC, Heyman M, et al: 6q
deletions in acute lymphoblastic leukemia and non-Hodgkin’s
lymphomas. Blood. 91:3397–3400. 1998.PubMed/NCBI
|
|
6
|
Minakhina S, Druzhinina M and Steward R:
Zfrp8, the Drosophila ortholog of PDCD2, functions in lymph gland
development and controls cell proliferation. Development.
134:2387–2396. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mu W, Munroe RJ, Barker AK and Schimenti
JC: PDCD2 is essential for inner cell mass development and
embryonic stem cell maintenance. Dev Biol. 347:279–288. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ramalho-Santos M, Yoon S, Matsuzaki Y,
Mulligan RC and Melton DA: ‘Stemness’: transcriptional profiling of
embryonic and adult stem cells. Science. 298:597–600. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skottman H, Mikkola M, Lundin K, et al:
Gene expression signatures of seven individual human embryonic stem
cell lines. Stem Cells. 23:1343–1356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan CW, Chan CC, Chao CC, Fan HA, Sheu DL
and Chan EC: Expression patterns of cell cycle and
apoptosis-related genes in a multidrug-resistant human colon
carcinoma cell line. Scand J Gastroenterol. 39:464–469. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lou Y, Peng Q, Nolan B, Wagner GC and Lu
Y: Oral administration of caffeine during voluntary exercise
markedly decreases tissue fat and stimulates apoptosis and cyclin
B1 in UVB-treated skin of hairless p53-knockout mice.
Carcinogenesis. 31:671–678. 2010. View Article : Google Scholar :
|
|
12
|
Baron BW, Hyjek E, Gladstone B, Thirman MJ
and Baron JM: PDCD2, a protein whose expression is repressed by
BCL6, induces apoptosis in human cells by activation of the caspase
cascade. Blood Cells Mol Dis. 45:169–175. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barboza N, Minakhina S, Medina DJ, et al:
PDCD2 functions in cancer cell proliferation and predicts relapsed
leukemia. Cancer Biol Ther. 14:546–555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Andreotti V, Ciribilli Y, Monti P, et al:
p53 transactivation and the impact of mutations, cofactors and
small molecules using a simplified yeast-based screening system.
PLoS One. 6:e206432011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yellapa A, Bitterman P, Sharma S, et al:
Interleukin 16 expression changes in association with ovarian
malignant transformation. Am J Obstet Gynecol. 210:272.e1–10. 2014.
View Article : Google Scholar
|
|
16
|
Everett SM, White KL, Drake IM, et al: The
effect of Helicobacter pylori infection on levels of DNA damage in
gastric epithelial cells. Helicobacter. 7:271–280. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Canzian F, Franceschi S, Plummer M, et al:
Genetic polymorphisms in mediators of inflammation and gastric
precancerous lesions. Eur J Cancer Prev. 17:178–183. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lazăr D, Tăban S, Sporea I, et al: The
immunohistochemical expression of the p53-protein in gastric
carcinomas. Correlation with clinicopathological factors and
survival of patients. Rom J Morphol Embryol. 51:249–257. 2010.
|
|
19
|
Liu X, Wang S, Xia X, et al: Synergistic
role between p53 and JWA: prognostic and predictive biomarkers in
gastric cancer. PLoS One. 7:e523482012. View Article : Google Scholar
|
|
20
|
Harrison JC and Haber JE: Surviving the
breakup: the DNA damage checkpoint. Annu Rev Genet. 40:209–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K
and Linn S: Molecular mechanisms of mammalian DNA repair and the
DNA damage checkpoints. Annu Rev Biochem. 73:39–85. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Jaarsveld MT, Wouters MD, Boersma AW,
et al: DNA damage responsive microRNAs misexpressed in human cancer
modulate therapy sensitivity. Mol Oncol. 8:458–468. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Smith GC, Cary RB, Lakin ND, et al:
Purification and DNA binding properties of the
ataxia-telangiectasia gene product ATM. Proc Natl Acad Sci USA.
96:11134–11139. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stracker TH, Usui T and Petrini JH: Taking
the time to make important decisions: the checkpoint effector
kinases Chk1 and Chk2 and the DNA damage response. DNA Repair
(Amst). 8:1047–1054. 2009. View Article : Google Scholar
|
|
25
|
Sun X, Liu B, Wang J, Li J and Ji WY:
Inhibition of p21-activated kinase 4 expression suppresses the
proliferation of Hep-2 laryngeal carcinoma cells via activation of
the ATM/Chk1/2/p53 pathway. Int J Oncol. 42:683–689. 2013.
|
|
26
|
Kokorina NA, Granier CJ, Zakharkin SO,
Davis S, Rabson AB and Sabaawy HE: PDCD2 knockdown inhibits
erythroid but not megakaryocytic lineage differentiation of human
hematopoietic stem/progenitor cells. Exp Hematol. 40:1028–1042.e3.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kramer J, Granier CJ, Davis S, et al:
PDCD2 controls hematopoietic stem cell differentiation during
development. Stem Cells Dev. 22:58–72. 2013. View Article : Google Scholar
|
|
28
|
Scarr RB and Sharp PA: PDCD2 is a negative
regulator of HCF-1 (C1). Oncogene. 21:5245–5254. 2002. View Article : Google Scholar : PubMed/NCBI
|
